Billiontoone (NASDAQ:BLLN) Reaches New 1-Year Low – Time to Sell?

Billiontoone, Inc. (NASDAQ:BLLN)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as $78.28 and last traded at $78.28, with a volume of 89205 shares traded. The stock had previously closed at $85.42.

Analyst Ratings Changes

Several analysts have commented on BLLN shares. Zacks Research raised shares of Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. JPMorgan Chase & Co. decreased their price objective on shares of Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, December 10th. Weiss Ratings initiated coverage on shares of Billiontoone in a research report on Tuesday, February 3rd. They set a “sell (d)” rating on the stock. William Blair initiated coverage on Billiontoone in a research report on Monday, December 1st. They issued an “outperform” rating for the company. Finally, Wall Street Zen raised Billiontoone to a “hold” rating in a report on Saturday, November 15th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Billiontoone has a consensus rating of “Moderate Buy” and an average price target of $135.29.

Billiontoone Stock Down 15.6%

The stock has a market cap of $3.30 billion and a P/E ratio of 721.00. The stock’s fifty day moving average price is $89.07.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings data on Tuesday, December 9th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.06). The company had revenue of $83.52 million during the quarter, compared to analyst estimates of $82.86 million.

Hedge Funds Weigh In On Billiontoone

Several large investors have recently bought and sold shares of the stock. Next Century Growth Investors LLC acquired a new stake in Billiontoone during the fourth quarter worth about $3,000,000. Adams Street Partners LLC acquired a new stake in shares of Billiontoone during the 4th quarter worth approximately $140,063,000. Capital International Investors acquired a new stake in shares of Billiontoone during the 4th quarter worth approximately $14,568,000. Seven Grand Managers LLC bought a new stake in shares of Billiontoone during the fourth quarter valued at approximately $2,046,000. Finally, Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone in the fourth quarter valued at $82,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.